A regenerative medicine group selling one offer through one small sales team. Client name withheld.
At $500K a month, every patient was offered the same thing by the same small team. That was the ceiling. The business could only grow as fast as one team could sell one product, and more leads wouldn't change that. They'd just fill the calendar sooner.
The single product line became three, so a patient who wasn't a fit for one had two more options.
They were hired and trained to one standard instead of three.
The ads and funnels were rebuilt, and new partnerships added, to keep three calendars full instead of one.
Regenerative medicine is regulated, and three teams selling it means three times the ways to get it wrong. Compliance protocols went in across every team.
Sales can outrun a clinic fast. Leadership, operations, patient care and compliance were built out alongside the teams, so the clinics could treat what was sold.
If one team sells one offer, that team is your ceiling. Buying more traffic just gets you there sooner. This group moved the ceiling by changing what it sold and who sold it, and then made sure the clinics could handle the volume.
Note on the numbers: Monthly sales and cash collected are from the company's own financials. Jake Solomon directed this engagement before he founded Revkeel. Results depend on the offer, the market and how well it's run. They are not typical and not guaranteed.
Nine numbers from last month. Your result shows on the page, no email needed.
Start with the diagnostic Case File 02: $207K to $2.27M a month